TY - JOUR
T1 - Economic evaluation of four drug administration systems in intensive care units in Colombia
AU - Rosselli, Diego
AU - Rueda, Juan David
AU - Silva, María Daniela
AU - Salcedo, Jorge
N1 - Funding Information:
Source of financial support: This study was financially supported by Baxter Laboratories S.A.
PY - 2014/12
Y1 - 2014/12
N2 - Introduction: Intensive care units (ICUs) are the most frequent setting for serious medical errors, which not only have serious health consequences but also an economic impact. In this article, using a theoretical model, we evaluate four medication administration systems: conventional preparation by nursing staff, MINIBAG Plus delivery system, compounding center preparation, and premix drugs. Methods: We designed a decision tree model from a third-party payer perspective, and the time horizon of the acute event. Local costs, in Colombian pesos (US $1 = 1784 COP$), were obtained from tariff manuals, medication costs from Sismed information system, and clinical variables from the published literature, and uncertainty was dealt with by an expert panel. The drug used for the model was dopamine. Results: Average costs for each dopamine dose delivered were $46,995 for premix, $47,625 for compounding center, $101,934 for MINIBAG Plus, and $108,870 for drug prepared in the ICU. The variability of these results is higher for compounding center than for premix, and even higher for MINIBAG Plus and nurse delivery. Conclusions: The use of premix drugs can be a cost-saving strategy, which decreases medical errors in drug administration in the ICU, particularly if it is part of an integral error reduction program.
AB - Introduction: Intensive care units (ICUs) are the most frequent setting for serious medical errors, which not only have serious health consequences but also an economic impact. In this article, using a theoretical model, we evaluate four medication administration systems: conventional preparation by nursing staff, MINIBAG Plus delivery system, compounding center preparation, and premix drugs. Methods: We designed a decision tree model from a third-party payer perspective, and the time horizon of the acute event. Local costs, in Colombian pesos (US $1 = 1784 COP$), were obtained from tariff manuals, medication costs from Sismed information system, and clinical variables from the published literature, and uncertainty was dealt with by an expert panel. The drug used for the model was dopamine. Results: Average costs for each dopamine dose delivered were $46,995 for premix, $47,625 for compounding center, $101,934 for MINIBAG Plus, and $108,870 for drug prepared in the ICU. The variability of these results is higher for compounding center than for premix, and even higher for MINIBAG Plus and nurse delivery. Conclusions: The use of premix drugs can be a cost-saving strategy, which decreases medical errors in drug administration in the ICU, particularly if it is part of an integral error reduction program.
KW - Drug administration schedule
KW - Drug delivery systems
KW - Economics
KW - Intensive care units
KW - Medication errors
UR - http://www.scopus.com/inward/record.url?scp=84904354191&partnerID=8YFLogxK
U2 - 10.1016/j.vhri.2014.05.001
DO - 10.1016/j.vhri.2014.05.001
M3 - Article
AN - SCOPUS:84904354191
SN - 2212-1099
VL - 5
SP - 20
EP - 24
JO - Value in Health Regional Issues
JF - Value in Health Regional Issues
ER -